Baihua Pharmaceuticals: Abnormal fluctuations in stock trading do not indicate undisclosed significant information that should be disclosed.

Baikang Medicine announced that the company's stock has deviated from the daily closing price by a cumulative 20% for three consecutive trading days from July 14 to 16, 2026, which is considered abnormal volatility. After self-inspection and verification with the controlling shareholder, it has been confirmed that, apart from the disclosed matters, there is no significant information that should be disclosed but has not been disclosed. Currently, the company's production and operation are normal, and there have been no significant media reports or market rumors that could have a major impact on the stock price. During the abnormal volatility period, there have been no transactions of the company's stock by relevant personnel. The company reminds investors to pay attention to trading risks.